4 completed, 2 terminated, 1 enrolling by invitation, 1 not yet recruiting. 4 Phase 1, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 2 | Enrolling by invitation 1, Not yet recruiting 1 |
Follow Phenelzine: new trials by email Literature Review of Phenelzine trials Research Report on Phenelzine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Care for Major Depressive Disorder Pramipexole, Methylphenidate, Phenelzine - Major Depressive Disorder, Depression | Phase 4 | Enrolling by invitation | University of California, San Francisco | 150 | 2024-11-12 | 2025-09-05 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants Placebo, Rasigiline, Phenelzine - Healthy Volunteers | Phase 1 | Completed | Celgene | 128 | 2021-07-19 | 2023-08-31 |
| A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure BI 1467335, Placebo, Phenelzine sulfate - Healthy | Phase 1 | Terminated | Boehringer Ingelheim | 53 | 2019-07-31 | 2021-06-04 |
| Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response Phenelzine, Tyramine, Phenelzine placebo - Healthy Volunteer | Phase 1 | Completed | Celgene | 92 | 2018-07-24 | 2019-07-19 |
| An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer Nanoparticle albumin-bound paclitaxel, Phenelzine Sulfate - Metastatic Breast Cancer | Phase 1 | Completed | EpiAxis Therapeutics | 8 | 2017-08-17 | 2019-11-13 |
| Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer phenelzine sulfate, laboratory biomarker analysis, questionnaire administration - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Completed | University of Southern California | 26 | 2014-09-08 | 2026-06-25 |
| Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel Biopsy of Prostate, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma | Phase 2 | Terminated | OHSU Knight Cancer Institute | 11 | 2010-07-12 | 2019-10-02 |
Prostatic Neoplasms (2) · Breast Neoplasms (1) · Depression (1) · Depressive Disorder, Major (1) · Panic Disorder (1)
Celgene (2) · Boehringer Ingelheim (1) · EpiAxis Therapeutics (1) · OHSU Knight Cancer Institute (1) · Sultan Qaboos University (1) · University of California, San Francisco (1) · University of Southern California (1)
United States (5) · Australia (1) · Netherlands (1)
Andrew D. Krystal, MD (1) · Desmond Yip, MBBS (1) · Jean C. Shih, PhD (1) · Jonathan Tran, Pharm.D (1) · Laeeq Malik, MBBS (1) · Massimo Attanasio, MD (1) · Mitchell Gross, MD (1) · Tomasz Beer (1)
2018 (1), P30CA014089 (1), P30CA069533 (1)